SEC Form 4 · accession 0001209191-16-135364
GigPeak, Inc. · GIG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi S Katz
Officer — President and CEO · Director
Period of report
Aug 1, 2016
Accepted (ET)
Aug 3, 2016 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001432150
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2016 | M | 8,050 | $0.00 | A | 73,391 | D | |
| Common StockF2,F3 | Aug 1, 2016 | F | 4,295 | $1.99 | D | 69,096 | D | |
| Common StockF4 | Aug 1, 2016 | M | 19,625 | $0.00 | A | 88,721 | D | |
| Common StockF5,F3 | Aug 1, 2016 | F | 10,470 | $1.99 | D | 78,251 | D | |
| Common StockF6 | Aug 1, 2016 | M | 38,702 | $0.00 | A | 116,953 | D | |
| Common StockF7,F3 | Aug 1, 2016 | F | 20,648 | $1.99 | D | 96,305 | D | |
| Common StockF8,F3 | Aug 1, 2016 | M | 14,907 | $0.00 | A | 111,212 | D | |
| Common StockF9,F3 | Aug 1, 2016 | F | 7,953 | $1.99 | D | 103,259 | D | |
| Common StockF10 | Aug 1, 2016 | M | 66,876 | $0.00 | A | 170,135 | D | |
| Common StockF11,F3 | Aug 1, 2016 | F | 35,679 | $1.99 | D | 134,456 | D | |
| Common StockF12 | Aug 1, 2016 | M | 3,260 | $0.00 | A | 137,716 | D | |
| Common StockF13,F3 | Aug 1, 2016 | F | 1,740 | $1.99 | D | 135,976 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs)F1,F14 | $0.00 | Aug 1, 2016 | M | 8,050 | D | — | — | Common Stock | 8,050 | 40,250 | D |
| Restricted Stock Units (RSUs)F4,F15 | $0.00 | Aug 1, 2016 | M | 19,625 | D | — | — | Common Stock | 19,625 | 176,625 | D |
| Restricted Stock Units (RSUs)F6,F16 | $0.00 | Aug 1, 2016 | M | 38,702 | D | — | — | Common Stock | 38,702 | 365,615 | D |
| Restricted Stock Units (RSUs)F8,F17 | $0.00 | Aug 1, 2016 | M | 14,907 | D | — | — | Common Stock | 14,907 | 14,906 | D |
| Restricted Stock Units (RSUs)F10,F18 | $0.00 | Aug 1, 2016 | M | 66,876 | D | — | — | Common Stock | 66,876 | 334,374 | D |
| Restricted Stock Units (RSUs)F12,F19 | $0.00 | Aug 1, 2016 | M | 3,260 | D | — | — | Common Stock | 3,260 | 35,861 | D |
Explanation of responses
- F18,050 Restricted Stock Units ("RSUs") issued in the grant to Dr. Katz on 8/1/2013 vested on 8/1/2016 according to the vesting schedule previously reported.
- F1066,876 RSUs issued in the grant to Dr. Katz on 7/19/2016 vested on 8/1/2016 according to the vesting schedule previously reported.
- F1135,679 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F123,260 RSUs issued in the grant to Dr. Katz on 7/19/2016 vested on 8/1/2016 according to the vesting schedule previously reported.
- F131,740 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F14The RSUs vest as follows: 25% vested on May 1, 2014. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2014 and ending on May 1, 2017, as previously reported.
- F15The RSUs vest as follows: 25% vested on May 1, 2015. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2015 and ending on May 1, 2018, as previously reported.
- F16The RSUs vest as follows: 25% vested on May 1, 2016. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2016 and ending on May 1, 2019, as previously reported.
- F17The RSUs vest in four quarterly installments beginning on February 1, 2016 and ending on November 1, 2016, as previously reported.
- F18The RSUs vest in six quarterly installments beginning on August 1, 2016 and ending on November 1, 2017, as previously reported.
- F19The RSUs vest in twelve quarterly installments, beginning on August 1, 2016 and ending on May 1, 2019, as previously reported.
- F24,295 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F3The closing price of the Company's common stock on 8/1/2016.
- F419,625 RSUs issued in the grant to Dr. Katz on 2/10/2014 vested on 8/1/2016 according to the vesting schedule previously reported.
- F510,470 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F638,702 RSUs issued in the grant to Dr. Katz on 3/26/2015 vested on 8/1/2016. As previously disclosed by the Company in its Current Report on Form 8-K, as filed with the SEC on July 20, 2016, and the Form 4 filed by Dr. Katz on that date, 60,106 total unvested RSUs from this award were rescinded on July 19, 2016, which results in 5,009 fewer RSUs vesting for the eleven remaining quarters, including this one, followed by one quarter of 5,007 fewer RSUs vesting. This rescission is reflected herein.
- F720,648 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F814,907 RSUs issued in the grant to Dr. Katz on 1/5/2016 vested on 8/1/2016 according to the vesting schedule previously reported.
- F97,953 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.